Drug Delivery Devices - Sweden

  • Sweden
  • In Sweden, revenue in the Drug Delivery Devices market market is projected to reach US$206.50m in 2024.
  • The revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 5.21%, leading to a market volume of US$266.20m by 2029.
  • In a global context, the majority of revenue will be generated the United States, which is forecasted to reach US$15,010.00m in 2024.
  • In Sweden, the demand for advanced drug delivery devices is rising, driven by increasing healthcare investments and a focus on patient-centric treatment solutions.
 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Drug Delivery Devices Market in Sweden is experiencing moderate growth, influenced by factors such as advancements in technology, increased patient needs for personalized medicine, and a rising focus on chronic disease management, which collectively enhance treatment efficiency.

Customer preferences:
In Sweden, there is a growing preference for drug delivery devices that offer convenience and personalization, reflecting cultural values of efficiency and individual health management. Patients are increasingly favoring devices that integrate with digital health platforms, enabling seamless monitoring and adherence to medication regimens. Additionally, the aging population is driving demand for solutions tailored to chronic disease management, while younger consumers prioritize user-friendly designs and connectivity features that align with their tech-savvy lifestyles.

Trends in the market:
In Sweden, the Drug Delivery Devices Market is experiencing a notable shift towards devices that emphasize user-centered design and interoperability with digital health ecosystems. The trend is marked by the increasing adoption of smart inhalers, wearable injectors, and connected infusion systems that facilitate real-time data sharing with healthcare providers. This shift is significant as it not only enhances medication adherence but also empowers patients in managing chronic conditions. As a result, industry stakeholders must prioritize innovation and collaboration to meet evolving consumer expectations and navigate regulatory landscapes effectively.

Local special circumstances:
In Sweden, the Drug Delivery Devices Market is shaped by a strong emphasis on innovation and sustainability, influenced by the country’s commitment to environmental responsibility and a robust welfare system. The Scandinavian culture promotes health and well-being, driving demand for advanced, user-friendly devices that integrate seamlessly with digital health platforms. Additionally, strict regulatory standards ensure high safety and efficacy, fostering consumer trust. This unique landscape encourages collaboration among stakeholders, enhancing the development of smart, connected solutions tailored to patient needs.

Underlying macroeconomic factors:
The Drug Delivery Devices Market in Sweden is significantly influenced by macroeconomic factors such as national healthcare expenditure, innovative healthcare policies, and demographic trends. With Sweden's commitment to a high-quality welfare system, public investment in healthcare infrastructure is robust, facilitating the adoption of advanced drug delivery technologies. Global trends, including the rising prevalence of chronic diseases and an aging population, further amplify demand for sophisticated, efficient delivery methods. Additionally, Sweden's focus on sustainability and green technologies aligns with consumer preferences, driving market growth while ensuring compliance with stringent regulatory standards that bolster safety and efficacy.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)